Mirae Asset Global ETFs Holdings’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$485K Buy
113,020
+980
+0.9% +$5.46K ﹤0.01% 1903
2025
Q4
$1M Sell
112,040
-2,918
-3% -$18.1K ﹤0.01% 1515
2025
Q3
$425K Sell
114,958
-21,739
-16% -$59.2K ﹤0.01% 1940
2025
Q2
$267K Buy
136,697
+28,150
+26% +$58.6K ﹤0.01% 2134
2025
Q1
$191K Buy
108,547
+4,608
+4% +$10.5K ﹤0.01% 2346
2024
Q4
$276K Buy
103,939
+5,693
+6% +$14.7K ﹤0.01% 2223
2024
Q3
$225K Buy
98,246
+25,031
+34% +$76.3K ﹤0.01% 2317
2024
Q2
$214K Buy
+73,215
New +$223K ﹤0.01% 2214

Other funds holding NUVB

Mirae Asset Global ETFs Holdings's NUVB Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Nuvation Bio (NUVB) stake by 0.87% in Q1 2026, buying an estimated $5.46K and bringing the position to 113,020 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Mirae Asset Global ETFs Holdings first reported a position in NUVB in Q2 2024 and has held it in 8 quarters since. The position peaked at $1M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 113,020 shares of Nuvation Bio worth $485K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 980 Nuvation Bio shares in Q1 2026, an estimated $5.46K.
  • Nuvation Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1903 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Nuvation Bio in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Nuvation Bio position peaked at $1M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.